Authors Information
1 Human Development and Health Academic Unit, Faculty of Medicine, The Institute of Developmental Sciences (IDS Building), MP887, Southampton General Hospital, University of Southampton, Tremona Road, Southampton SO16 6YD, UK
Department of Medicine and the Diabetes Translational Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
3 Departments of Medicine and Epidemiology, Johns Hopkins University Schools of Medicine and Public Health, Baltimore, MD, USA
- Author information
- Copyright and License information
- For more information on the relationship between diabetes and depression, please visit the following websites:
American Diabetes Association – Depression and Diabetes
National Institute of Mental Health – Depression
Understanding the Link Between Diabetes and Depression
Diabetes and depression often coexist, impacting the outcomes of both conditions. Shared biological and behavioral mechanisms such as inflammation, lifestyle, and cultural factors may be driving forces behind both. Effective care pathways involving a multidisciplinary team are crucial for achieving optimal results.
Keywords: Depression, Diabetes, Screening, Treatment, Mechanisms
The Challenge of Comorbid Diabetes and Depression
Around 8.3% and 10% of the global population are affected by diabetes and mental illness, respectively, with a significant overlap between diabetes and depression. This combination poses difficulties for clinical outcomes, leading to more complications and treatment costs without substantial improvements in the quality of life.
Although the connection between mental illness and diabetes has been acknowledged for centuries, it is often neglected in diabetes care. This review delves into the correlation between these two conditions, highlighting their epidemiology, pathogenesis, and treatment options.
Sourcing Information on Diabetes and Depression
This review was compiled using data from PubMed searches and the 2012 International Diabetes and Depression Conference. Hosted by NIDDK, NIH, NIMH, and the Dialogue on Diabetes and Depression, the conference provided valuable insights into these conditions.
Depression can have a significant impact on diabetes management. Not only does it make it harder for individuals to stick to their self-care routine, such as monitoring blood sugar levels and adhering to medication regimens, but it can also lead to poor dietary choices and lack of physical activity. This can result in poorly controlled blood sugar levels and an increased risk of diabetes-related complications.
It is important for healthcare providers to screen for depression in individuals with diabetes and to provide appropriate support and resources. Cognitive behavioral therapy, medication, and support groups have been shown to be effective in managing depression in diabetics. Additionally, addressing lifestyle factors, such as exercise and stress management, can also help improve both mental health and diabetes control.
Theoretical Models Exploring the Diabetes-Depression Link
Psychological Impact on Diabetes Management
Depression in diabetes may stem more from the challenges of managing the disease than from biological mechanisms. Healthcare professionals play a critical role in alleviating the psychological burden of diabetes through accurate diagnosis, communication, and psychosocial support.
Lifestyle Factors and the Comorbidity of Depression and Diabetes
Sedentary behavior and poor diet choices may contribute to the co-occurrence of depression and diabetes. These factors can elevate the risk of developing type 2 diabetes.
Non-adherence to self-care management and depressive symptoms are significantly linked to non-compliance with diabetes treatment recommendations, including missed appointments, dietary restrictions, exercise, medication adherence, glucose monitoring, and foot care. Research suggests a reciprocal relationship where poor self-care adherence may elevate blood sugar levels, contributing to depressive symptoms and reduced adherence to self-care practices.
Antidepressant use may also pose a risk for diabetes, as documented in case reports and observational studies linking antidepressants with diabetes. Randomized controlled trials demonstrate varying effects of antidepressants on weight gain and blood sugar levels.
Shared biological changes occur in diabetes and depression, increasing the risk of both conditions. Common mechanisms may underlie these conditions, focusing on shared pathogenic pathways rather than the direction of association.
Hypoglycemia, hyperglycemia, and brain function changes triggered by diabetes can impact mood. Diabetes can influence brain integrity and neurogenesis, potentially contributing to mood-related symptoms. Dysfunction of the hypothalamic-pituitary adrenal axis is associated with both depression and diabetes.
Disrupted sleep patterns, linked to depression, may raise insulin resistance and the risk of type 2 diabetes. Chronic inflammation may be a key factor connecting depression and diabetes.
Environmental influences, from intrauterine conditions to neighborhood settings, can affect the likelihood of comorbid depression and diabetes. Unfavorable environments are correlated with poorer health outcomes.
Comorbid depression negatively affects diabetes outcomes and quality of life. Studies demonstrate a relationship between depression severity, diabetes symptoms, and glycemic control, with depression intensifying the severity of diabetes complications.
Effectively managing depression starts with early recognition and diagnosis. Reliable and cost-effective screening methods are essential in primary and secondary care settings. Various well-established depression screening tools, such as the PHQ-9, are used among individuals with diabetes.
Overall, understanding the interplay between depression and diabetes involves shared biological mechanisms, environmental factors, and effective strategies for managing comorbid conditions.
Assessment Tool
Primary Care Health Questionnaire (PHQ-9)
A self-report assessment of depressive symptoms that evaluates DSM-IVTR criteria for Major Depressive Disorder
Other Assessment Tools Include:
Beck Depression Inventory (BDI-II)
Center for Epidemiologic Studies – Depression Scale (CESD)
Hospital Anxiety and Depression Scale (HADS)
Information adapted from a systematic review on screening tools for depression in individuals with Type 1 and Type 2 diabetes (Roy T, Lloyd CE, Pouwer F, Holt RI, Sartorius N. Diabetes Med. 2012;29:164–75).
Diabetes healthcare professionals may use two simple questions to screen for depression:
If the answer is affirmative to either question, further assessment and appropriate referral for treatment should be offered.
Patient-specific decisions should be made regarding psychological therapies and antidepressant medication. An equal emphasis on both diabetes and depression is crucial, as poor metabolic control, infrequent blood glucose monitoring, and diabetes-related complications predict inadequate response to depression treatment.
Until recently, individuals with diabetes were excluded from depression treatment trials, limiting data on antidepressant and psychotherapy efficacy for this population. However, recent studies have demonstrated the effectiveness of treating depression in individuals with diabetes.
Psychotherapy protocols typically involve cognitive behavioral therapy, problem-solving, interpersonal therapy, motivational interviewing, counseling, and psychodynamic therapy. Combining psychological interventions with diabetes education yields positive outcomes by equipping individuals with self-management skills and psychological support.
Web-based psychological therapies may effectively treat depression in individuals with diabetes, although their impact on glycemic control may be limited. Integrating psychological interventions with diabetes education offers seamless and beneficial support for patients.
Studies on antidepressant medications for individuals with type 1 or type 2 diabetes have shown short-term improvements in depressive symptoms with appropriate dosages. While efficacy trials have shown diverse outcomes, evidence for several commonly prescribed antidepressants remains insufficient. The choice of treatment should consider side effects, patient preferences, and individual responses. Selective serotonin reuptake inhibitors are preferable due to lower cardiotoxicity and overdose risks. Some antidepressants may lead to weight gain and worsen insulin resistance, while others, like bupropion, support weight loss without affecting sexual function.
Antidepressants have varying effects on glycemic control, with tricyclic antidepressants causing hyperglycemia and selective serotonin reuptake inhibitors leading to euglycemia or mild hypoglycemia. Sertraline, specifically, may offer benefits for glycemic control.
In the realm of healthcare, there is a common oversight of individuals dealing with both physical and mental illnesses concurrently, which can have a negative impact on diabetes management. The implementation of multidisciplinary team-based approaches for treating depression in primary care settings has been proven to yield favorable results. By fostering collaboration between primary care providers, endocrinologists, and mental health specialists, it is possible to enhance not only depressive symptoms but also glycemic control and overall health outcomes.
The coexistence of diabetes and depression presents a complex challenge in clinical practice. It is paramount for healthcare professionals to promptly recognize and address depression in patients with diabetes in order to maximize clinical results. The provision of expanded access to mental health services and specialized care is vital in effectively addressing this pressing public health concern.
This article extends appreciation to the other contributors of the NIDDK conference’s Planning Committee. Furthermore, it is part of the Topical Collection on Diabetes and Other Diseases-Emerging Associations, highlighting ethical considerations such as human and animal rights, informed consent, and conflict of interest. The key contributors and their respective affiliations are duly acknowledged, with particular emphasis placed on noteworthy papers.